We often profile customers who are working on particularly interesting genetic research projects on The Genetic Link, in the hope that it will benefit other customers. Dr. Nasir Ali Afsar MBBs, M.Phil, Ph.D. from the College of Medicine at Alfaisal University in Saudi Arabia is one such researcher with a project we thought was worth sharing.
DNA Genotek's Sample Collection Blog
The author of this article, Lisa Gamwell, is a Sales Development Analyst at DNA Genotek.
In this recent article, we took an in-depth look at DNA Genotek’s customer service and technical support to understand why our customers value it so much. This week, we’re examining a slightly different angle on customer feedback to illustrate how much we value what you have to say.
DNA Genotek is proud to provide a high level of service and support to our customers. We know that our success as a company is tightly integrated with the success of our customers and we are committed to providing access to a team of skilled scientists and creative resources to optimize genetic projects from sample collection through to downstream processing.
Dr. Janet Coller, Lecturer at the University of Adelaide, has an established track record in Pharmacology and Pharmacogenetic medical research within the health areas of cancer, drug dependence, cardiology and solid-organ transplantation. Her research includes work to identify how genetic variability impacts the therapeutic use of tamoxifen for breast cancer, identifying important genetic variants that determine successful treatment of opioid dependence with methadone, and research in the emerging field of immunogenetics.
You’ve heard us say that our commitment to quality spans all aspects of our internal procedures from customer support to product development and manufacturing – but what does this really mean? Does a quality program really make an impact?
Telomeres are an emerging area of genetic research with many new studies being published that highlight fascinating results. Telomeres reside at the end of each chromosome in our bodies. They have no genetic function and are simply stretches of DNA that protect the rest of the chromosome. However, these little bits of DNA, or telomeres, are critical to healthy cell function. They become shorter each time the cell divides. Telomere shortening means the cell’s lifespan is also decreasing. Recent research shows that decrease in telomere length plays an important role in human disease and mortality with many studies showing associations between shorter telomere length and various types of cardiovascular disease, cancer, osteoporosis, cognitive function, dementia, and arthritis. On the flip side, long telomeres are related to healthy aging and overall longevity.
Mike Tayeb is the Technical Support Manager at DNA Genotek Inc.
We are very excited to tell you about a new initiative we announced today as part of the DNA Genotek Helping Hands Program. Spit for Africa is a new sponsorship program in conjunction with the African Society of Human Genetics (AfSHG). Spit for Africa is designed to improve access and reduce the cost of DNA collection for locally and internationally funded genomic projects such as the Human Heredity and Health in Africa (H3 Africa) Initiative and to facilitate growth in membership of the AfSHG.
Through their participation in the IMPACT research study (Individualized Medicine: Pharmacogenetic Assessment & Clinical Treatment), practitioners in Canada are now able to offer certain patients a saliva-based genetic test to predict which psychiatric medications work best for them. The tests enable physicians to use a patient’s genetic makeup to help predict which medications are safe to prescribe, and which ones may be ineffective or cause side effects. The tests are aimed at minimizing trial-and-error prescribing/dosing and are expected to reduce associated health care costs. The pharmacogenetic tests, currently offered to Centre for Addiction and Mental Health (CAMH) clients and registered patients at the Thornhill Medical Centre, use DNA from saliva collected with Oragene for the purposes of the research. Plans are being made to incorporate several other Ontario healthcare facilities into the IMPACT study. This study is making the promise of personalized medicine a reality.